SmartTRAK Life Sciences News and Analysis Blog in the Orthopedics, Wound, and Neuro Therapies Market Segments
.png)
SmartTRAK reviews how the changes to skin substitute reimbursement reforms may impact each site of servi...
Wound GM Kris Flinn and Senior Analysts Elizabeth Anderson and Jay Merkel discuss the impact of the fina...
SmartTRAK reviews possible alternatives to LCDs and CMS’ proposed payment model for Cellular, Acellular,...
SmartTRAK's industry experts discuss CMS’ proposed changes to skin substitutes reimbursement and their p...
SmartTRAK reviews CMS’ new WISeR model and its potential impact on the US Skin Substitutes Market. A new...
Wound GM Kris Flinn and Senior Analysts Elizabeth Anderson and Jay Merkel discuss the impact of delay an...
SmartTRAK looks at the market’s response to the recently finalized LCDs and the potential impact on the ...
SmartTRAK believes the billions of dollars of Medicare abuse already uncovered is the tip of the iceberg...
The proposed MAC LCDs for Skin Substitutes/CTPs was the hot topic of SAWC and will continue to be until ...
All seven MACs, in a united front, released proposed changes to the LCDs, which govern Skin Substitute/C...
Login